Some women sail through Mounjaros titration with barely a second thought
Opportunities Outside of Diabetes and Obesity Additional Indications for Exploration Additional Indications for Exploration As new companies look to enter the incretin mimetic space, and existing players seek to expand their portfolios, its increasingly important to look beyond diabetes and obesity
And just as a reminder, the content in this podcast episode is no substitute for medical advice, diagnosis, or treatment from your medical or licensed health care team
- Flow Wellness, accessed April 22, 2025, 8 Zepbound Side Effects: Common and Severe and How to Manage Them - NP2GO, accessed April 22, 2025, GLP-1 physiology informs the pharmacotherapy of obesity - PubMed, accessed April 22, 2025, Creating a GLP-1 Meal Plan | Visit MRC Auburn - Metabolic Research Center, accessed April 22, 2025, Food Noise and Semaglutide: Can GLP-1 Medications Quiet the Chatter